Company ProfilePremium

IperionX Limited (formerly Hyperion Metals Limited)

Company Profile Analysis

Ticker: IPX.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
IperionX Limited - Company showcase

Year Founded & Workforce

2017

IperionX Limited logo

IperionX Limited Employee Contacts

4 verified contactsNames, job titles, seniority and locations

View Employee Contacts

IperionX Limited Overview

IperionX is a pre-scale, US-focused titanium metal and critical-minerals company. It is building a vertically integrated domestic titanium supply chain that runs from mineral sands to finished components. Its core intellectual property is a family of patented powder-metallurgy processes. HAMR™ (Hydrogen Assisted Metallothermic Reduction) de-oxygenates titanium feedstock (scrap or mineral) into low-cost titanium powder. HSPT™ (Hydrogen Sintering and Phase Transformation) and related downstream processes turn that powder into near-net-shape titanium parts such as fasteners. The company says HAMR produces titanium powder at 40–70% lower cost than the incumbent Kroll process. Operations centre on a Titanium Manufacturing Campus in South Boston, Virginia. This campus moved to 24/7 production in the March 2026 quarter and targets an annualised run-rate of about 200 tpa of powder by end-CY2026, scaling to about 1,400 tpa with US Department of Defense (DoD/"Department of War") IBAS funding. Upstream, it owns the Titan Critical Minerals Project in Tennessee, whose DFS shows an after-tax NPV8 of US$813M. Commercially, the company is still at the pre-revenue/early-revenue stage and depends heavily on government funding.


What the company does

IperionX positions itself as an American titanium metal and critical materials company. It uses patented technologies to make high-performance titanium alloys from titanium minerals or scrap titanium, and claims lower energy use, cost and carbon emissions than conventional routes (company description as syndicated via FNN, July 2026). The business has two linked pillars.

  1. Titanium metal and products (Virginia). HAMR converts titanium feedstock into titanium powder that the company says meets or exceeds Grade 5 (Ti-6Al-4V) quality parameters [Q4 FY26]. Downstream processes (HSPT™, THRM™ and powder metallurgy pressing) turn the powder into near-net-shape components. The company commissioned a six-axis powder metallurgy press in May 2026 and says it triples existing powder-metallurgy capacity [Q4 FY26]. Spherical powders for additive manufacturing are also in qualification [Q3 FY26].

  2. Critical minerals (Tennessee). The 100%-owned Titan Project near Camden, Tennessee is a near-surface, free-dig mineral sands deposit. It is designed to produce ilmenite, rutile, zircon and a Heavy Rare Earth Concentrate (HREC). The DFS supports an initial 14-year mine plan [DFS]. The adjacent Atlas property was acquired on 1 July 2026 for US$3M [Q4 FY26].

Business and revenue model

Revenue / funding streamStatus (latest disclosure)Character
Titanium powder sales (direct)Production in ramp-up; supports qualification programmes and direct powder requirements [Q4 FY26]Product
Near-net-shape titanium components (fasteners, pump/valve parts, defence parts)Prototype and qualification orders; US Army GVSC prototype fastener order for the Joint Light Tactical Vehicle (JLTV), July 2026Product (engineered)
US Government contracts and awardsIBAS US$47.1M (fully obligated); DPA Title III US$12.7M; SBIR Phase III contract vehicle up to US$99M [20-F FY26 summary via Quartr]Cost-reimbursement funding and contract revenue
Mineral concentrates (ilmenite, rutile, zircon, HREC)Pre-development; DFS complete, project finance neededFuture product
Licensing of IPNo licensing revenue disclosed—

The company's stated core growth opportunity is finished titanium components rather than powder. It made this point explicitly in its November 2025 response to Spruce Point. Management expects customer revenue to begin and scale in 2H CY2026 as qualification programmes convert to purchase orders [Q3 FY26].

Value chain position

IperionX aims to cover the full chain: mineral sands mining (Titan/Atlas), then primary titanium metal powder (HAMR, which bypasses Kroll sponge and melting), then alloy powder, then near-net-shape and finished components (HSPT/press/AM). Its scrap-to-powder route also lets it take in titanium scrap; the US Government has transferred scrap to the company, including about 290 metric tonnes cited alongside a final US$4.6M DoW funding payment.

Customer types and end-markets

Target sectors disclosed: defence (US Army GVSC, DoD programmes), aerospace, automotive (Ford contract cited in Q3 FY26 materials), consumer electronics (spherical AM powders under qualification), and industrial uses such as pump and valve parts [Q3 FY26].

Independent characterisation

IperionX is effectively a government-anchored industrial scale-up story. In FY2026 it carried a net loss of US$66.8M with no material revenue. Its main assets are (i) a process-technology portfolio now running continuously at small commercial scale, (ii) a de-risked but unfunded US critical-minerals deposit, and (iii) a strong policy tailwind from US efforts to re-shore titanium and rare-earth supply chains. The investment case rests on converting qualification work into recurring component revenue before the funding window closes. That conversion has not yet been demonstrated at scale.

Strategy

Stated strategic themes (2026 shareholder letter, Q3/Q4 FY26 reports, paraphrased):

  1. Re-shore and build the world's lowest-cost titanium supply chain in the US using patented technologies.

  2. 2026 operating priorities: increase titanium throughput, broaden product mix, improve production consistency, and commission more downstream capacity [Q3 FY26].

  3. Capacity roadmap: ~200 tpa powder run-rate by end-CY2026, ~1,400 tpa in 2027 (IBAS-funded), and more than 10,000 tpa of components by 2030 [Quartr FY26 summary; HY26].

  4. GenX™: continuous HAMR for capital-efficient scaling through 2030.

  5. Upstream integration: Titan DFS completed (June 2026); Atlas acquired (July 2026); an integrated Atlas–Titan economic assessment is targeted by end-2026 to quantify capital and schedule benefits [Q4 FY26].

  6. Customer conversion: move qualification programmes (defence, aerospace, automotive, consumer electronics, industrial) into defined purchase orders, with revenue starting in 2H CY2026 [Q3 FY26].

Medium-term financial targets: no formal revenue or EBITDA guidance has been published. ESG positioning is low-energy, low-carbon titanium production (see §20).

Products & Services

Titanium metal and products

OfferingDescription / capabilityTarget customerStatus / yearPricing
HAMR™ titanium powderHydrogen Assisted Metallothermic Reduction de-oxygenates titanium scrap or mineral feed into titanium/alloy powder; company claims cost 40–70% below Kroll by skipping sponge and melt stepsPowder buyers, own downstream useCommercial-scale systems commissioned and in ramp-up (2026); run-rate target ~200 tpa by end-CY2026—
GenX™ continuous HAMRNext-generation continuous HAMR platform aimed at higher productivity and capital efficiencyInternal (capacity scaling)Unveiled Feb 2026; commercial-scale validation targeted in 2026—
Grade 5 (Ti-6Al-4V) alloy powderPowder meeting or exceeding Grade 5 quality parametersAerospace, defence, industrialProduction FY2026 [Q4 FY26]—
Spherical AM powdersTitanium powders for additive manufacturingConsumer electronics, AM usersQualification in progress [Q3 FY26]—
HSPT™ near-net-shape partsHydrogen Sintering and Phase Transformation; validated at finished-product level [Q4 FY26]Defence, aerospace, automotivePrototype/qualification—
THRM™ processingAdditional proprietary process validated with HSPT at finished-product level [Q4 FY26]As abovePrototype/qualification—
Titanium fastenersIndependent testing (US Army DEVCOM GVSC; Westmoreland Mechanical Testing & Research) showed torque yield above SAE Grade 8 steel and tensile values above common aerospace titanium-fastener standardsUS Army (JLTV), defence, aerospacePrototype orders 2025–26—
Powder-metallurgy pressed componentsSix-axis PM press triples PM capacity and widens the range and complexity of partsIndustrial, defenceCommissioned May 2026—
Heavy ground-combat-system componentsPrototype order for a US Army heavy ground combat system (TipRanks headline)US ArmyPrototype—

Critical minerals (future products, Titan/Atlas)

ProductPhase 2 annual output (DFS)Use
Ilmenite118,658 tpaTitanium feedstock (HAMR) and pigment markets
Rutile24,656 tpaHigh-grade titanium feedstock
ZirconDisclosed in DFSCeramics, refractories
Heavy Rare Earth Concentrate (HREC)Disclosed in DFSMagnet supply chain

Financial Narrative

Income statement

Sources: FY2026, FY2025 and FY2024 net loss from 20-F FY26 Note 18 (accumulated losses table: US$66,767,762; US$35,348,675; US$21,843,646). EPS and finance income FY2024–25 from the FY2025 Directors' Report (6-K).

Gross profit, operating income, EBITDA, pre-tax income and margins are not meaningful for a pre-revenue company, so margin rows are omitted. Marketscreener records reported EBITDA of about -21.6 (FY2024) and -36.3 (FY2025), USD M; these are aggregator figures. Revenue CAGR is not computable.

Half-year detail (H1 FY26 vs H1 FY25, USD M, per HY26 / Kalkine):

Data conflict: Kalkine reports H1 FY25 operating outflow as 11.48 and H1 FY25 financing as 6.21. The HY26 cash-flow statement (SEC 6-K) shows 11,748,806 and 68,206,221. The primary filing is preferred here.

Balance sheet

Interim points: at 31 Dec 2025, cash was US$65.8M, net assets US$108.2M and total assets about US$129.2M [HY26; VCP Scanner]. At 31 Mar 2026, cash was US$48.2M [Q3 FY26]. Pro-forma cash after the July 2026 raise and grant reimbursements was about US$84M (Panabee summary of Q4 FY26).

Total debt, net debt and working capital: the company is funded by equity and government grants [20-F FY25] and has no disclosed borrowings. Right-of-use assets at 30 June 2025 were US$3,752,600 (as corrected, 13 March 2026). Goodwill and intangibles: not disclosed separately in materials retrieved.

Cash flow

FY2025 operating cash flow is from FinancialFilings (citing the Annual Report filed 14 Oct 2025). The combined operating and investing outflow is from 20-F FY25. Implied FY2025 investing outflow is about -24.3. VCP Scanner reports FY2025 free cash flow of -54.7; this conflicts with the filing-derived -46.1 (operating plus investing, before netting any grant inflows) and is likely a definitional difference. The June 2026 quarter's operating cash burn was about US$12M (Panabee).

Equity raises:

Ratios

ROE, ROA and ROIC are all deeply negative. FY2026 ROE is about -75% on closing equity (66.8 / 88.3, simple calculation). Interest coverage, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful: there is no material revenue, EBITDA is negative, and there is no disclosed debt.

Commentary

The loss trajectory has steepened, from about US$22M in FY2024 to US$35M in FY2025 to US$67M in FY2026. The drivers are a step-up in R&D, ramp-up and commissioning costs in Virginia, exploration and DFS work at Titan, and much higher corporate and administrative expense. That expense rose almost fivefold in H1 FY26, reflecting a larger US team, dual-listing compliance and the costs of defending against the short-seller campaign.

The company has repeatedly ended years with cash below its annual burn and refilled the balance sheet through equity raises: A$70M in 2025 and US$50M in July 2026. FY2026 closing cash of US$35.2M fell within the company's guided range of US$36–40M only at the lower edge; strictly, it was slightly below. Government funding offsets part of the capital expenditure.

The key inflection to watch is whether product revenue appears in FY2027, as consensus models assume (see §21–22).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Revenue

Segment / activity (analyst grouping)ContentsProductsRevenue FY2024Revenue FY2025

Titanium metal & products

Virginia campus (HAMR, HSPT, THRM, PM press, AM powders); Utah facility

Ti powder, near-net-shape parts, fasteners

Nil disclosed

Nil disclosed

Critical minerals

Titan Project and Atlas property (Tennessee)

Ilmenite, rutile, zircon, HREC (future)

Nil

Nil

Segment revenue (USD Mn)

Segment revenue (USD Mn)FY2024FY2025FY2026

Titanium metal & products

00—

Critical minerals

000

Key Financials and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (USD Mn)

0000—

Net loss after tax (USD Mn, negative)

-21.5-17.4-21.8-35.3-66.8

Finance income (USD Mn)

——0.53.6—

Basic & diluted EPS (USD per ordinary share)

——-0.10-0.12—

Dividends per share (USD)

00000

Cash Flow

Metric (USD Mn)H1 FY25H1 FY26

Loss for the period

-16.24-34.76

Corporate & administrative expense

3.2816.21

Business development expense

2.151.65

Share-based payments expense

6.914.67

Net cash used in operating activities

-11.75-16.70

Net cash used in investing activities

-10.97-16.38

Net cash from financing activities

68.2143.92

Balance Sheet

MetricFY2024FY2025FY2026

Cash & equivalents (USD Mn)

33.254.835.2

Total assets (USD Mn)

—105.0—

Net assets / equity (USD Mn)

—92.488.3

Accumulated losses (USD Mn, negative)

-73.9-109.2-176.0

Cash Flow (Annual)

MetricFY2024FY2025FY2026

Operating cash flow (USD Mn)

—-21.8—

Operating + investing outflow (USD Mn, negative)

-25.1-46.1—

Dividends paid (USD Mn)

000

Buybacks (USD Mn)

000

Raise Details

RaiseDateGross proceeds

Placement, 14.0M shares at A$5.00 (tranche 1), total A$70M

Jul–Oct 2025

~US$46M

Underwritten Nasdaq ADS offering, 2,275,000 ADS at US$21.98

7–9 Jul 2026

~US$50M

Geographic revenue (USD Mn)

Geographic revenue (USD Mn)FY2024FY2025FY2026

United States

00—

Australia

000

Rest of world

000

Data Point Details

Data pointValueSource / date

ASX close

A$4.15

7 Jul 2026 (prospectus)

Nasdaq ADS close

US$28.36

6 Jul 2026

Offering price

US$21.98/ADS

7 Jul 2026

Nasdaq ADS

US$24.10; market cap ~US$895M

14 Aug 2026

Nasdaq 52-week range

US$20.09 – US$61.45

As of 14 Aug 2026

ASX 2026 range (to ~late Jul)

Open A$5.51; high A$8.44; low A$3.05; down ~41% YTD

InvestSMART

Nasdaq total return CAGR

1-year ~56%; 3-year ~84% (as of 4 Mar 2026)

iOCharts

Analyst Ratings & Targets

BrokerRatingTarget (USD)Note

Roth Capital

Buy (implied)

53 (cut from 75)

2,026

Texas Capital (M. Key)

Buy

55

Initiation 2026

BTIG

Buy

55 (from 40)

—

William Blair

Outperform

—

Initiation

Consensus (StockAnalysis)

—49.40

Recent

Income Statement

Consensus forecast (USD Mn)FY2026FY2027FY2028

Net sales consensus (USD Mn)

12.681.7252

EBITDA consensus (USD Mn)

-19.728.2139

Net income consensus (USD Mn)

-19.912.3136

Analyst Conclusions

Guidance: ~200 tpa powder run-rate by end-CY2026; ~1,400 tpa in 2027; more than 10,000 tpa of components by 2030; customer revenue to start in 2H CY2026; integrated Atlas–Titan study by end-2026.

Bull case

  1. The HAMR ramp to 200 tpa, with Grade 5 output, proves the cost advantage. The IBAS-funded jump to 1,400 tpa then creates real operating leverage.

  2. Defence fastener qualification (JLTV, ground combat systems) converts into programme volumes under the SBIR III vehicle, which is worth up to US$99M.

  3. The Titan DFS (NPV8 US$813M) alone approaches the company's recent market cap, so the metals business is effectively a free option if Titan is financed.

Bear case

  1. FY2026 loss of US$66.8M against US$35.2M cash, with repeated discounted raises, points to further dilution.

  2. Revenue timelines have slipped and consensus has been badly wrong, as the FY2026 loss forecast of -19.9 against actual -66.8 shows.

  3. Control lapses (March 2026 correction), active shorts and potential litigation keep the stock at a credibility discount.

Catalysts and monitorables (next 12 months): the September 2026 quarterly (29 Oct 2026), especially throughput, first revenue and cash; whether 200 tpa is reached by December 2026; GenX™ validation data; the Atlas–Titan study; Titan project-finance progress (government lenders, offtake); GVSC and Ford order conversion; short-seller follow-ups; the status of securities claims.

Analyst verdict. IperionX has advanced further than most of its powder-metallurgy peers. It is running a patented primary-titanium process 24/7 at commercial scale in the United States, its output meets Grade 5 specifications, and its components have passed independent defence testing. Washington has visibly committed to the company through IBAS, DPA Title III and an SBIR Phase III vehicle, and through scrap transfers. The Titan DFS adds a credible, permitted upstream asset with headline economics that look attractive relative to the equity value.

Yet the financial record remains that of a development company. FY2026 losses nearly doubled to US$66.8M, cash ended the year at US$35.2M, and accumulated losses reached US$176M. The company has had to raise equity twice in about twelve months, most recently at a steep discount. The March 2026 correction was immaterial in accounting terms, but it gave short sellers a narrative and cost management credibility at a sensitive moment. Revenue guidance has repeatedly moved to the right, and the published consensus is clearly stale.

The investment question is therefore narrow and binary over the next four to six quarters. Can Virginia demonstrate repeatable throughput near 200 tpa, with recognisable unit costs and the first recurring purchase orders, before another raise is needed? If yes, the 1,400 tpa expansion is already government-funded and the equity story could re-rate. If no, dilution compounds and the Titan option may have to be monetised on weaker terms.

On balance, we view IperionX as a high-risk, policy-levered special situation. Verification of the 29 October 2026 quarterly report should be treated as the next decision point.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleNotes

Anastasios (Taso) Arima

Founder, CEO & Managing Director

Bought shares on market in Feb, Mar and Apr 2026

Toby Symonds

President

Named in company contacts (2026 releases)

Dominic Allen

Chief Commercial Officer

Named in company contacts

Marcela Castro

Chief Financial Officer (principal financial officer)

Signed SOX s.906 certification, 29 Sep 2026

Board of Directors

NameRoleRecent dealings

Todd Hannigan

Chair (Executive Chair per company disclosures; verify title in 20-F FY26)

Bought 480,000 shares (29 Apr 2026, ~A$2.08M); bought 225,225 (27 Mar 2026); exercised/bought 159,333 (Feb 2026); issued securities Apr 2026

Lorraine Martin

Non-executive director

Bought 47,550 shares (28 Apr 2026)

Vaughn Taylor

Non-executive director

Sold 150,000 shares (4 Feb 2026, ~A$1.03M)

Melissa Waller

Non-executive director

Sold 150,000 shares (15 Sep 2025, ~A$1.0M)

R. (Tony) Tripeny

Non-executive director

Bought 41,870 shares (23 Dec 2025)

Competitive Landscape

Key Competitors

CompetitorSegment overlapPositioning vs IperionX

VSMPO-AVISMA (Russia)

Titanium sponge, mill products

World's largest integrated producer; geopolitically constrained in Western markets

Toho Titanium (Japan)

Kroll sponge, powders

Established Kroll incumbent; supplies Western aerospace

OSAKA Titanium Technologies (Japan)

Kroll sponge, powders

Established incumbent

ATI Inc. (US)

Titanium mill products, specialty alloys

Scale incumbent and potential customer/competitor

Howmet Aerospace (US)

Titanium components, fasteners

Major aerospace fastener incumbent

Precision Castparts / TIMET (Berkshire Hathaway)

Integrated titanium, fasteners

Major US incumbent

Carpenter Technology (US)

Specialty alloys, AM powders

Powder and AM competitor

6K Additive (US)

Recycled AM powders

Powder competitor

Amaero (ASX: 3DA)

US atomised titanium AM powder

Direct powder peer

Titomic (ASX: TTT)

Cold-spray titanium

Adjacent ASX peer

Iluka Resources / Chemours (mineral sands)

Ilmenite, rutile, zircon

Upstream incumbents relative to Titan

MP Materials / Energy Fuels

Rare earths

HREC market context

Peer Comparison FY2026

MetricIperionX (FY2026)ATI (FY2024)Howmet (FY2024)Carpenter (FY2025, Jun)

Revenue (USD Mn)

—

~4,360

~7,430

~2,880

Net result (USD Mn)

-66.8———

R&D intensity

n/m

———

Recent Developments

--

Company Snapshot

$895M

Market Cap

2017

Founded

Virginia, US

Headquarters

SWOT Analysis

Strengths

  • Continuous 24/7 commercial-scale production since the March 2026 quarter, with all HAMR systems commissioned [Q3 FY26].
  • HAMR powder consistently meets or exceeds Grade 5 parameters [Q4 FY26].
  • Third-party validation: fasteners beat SAE Grade 8 steel torque yield in US Army DEVCOM GVSC and Westmoreland testing.
  • Deep US Government support: IBAS US$47.1M (fully obligated), DPA Title III US$12.7M, SBIR III up to US$99M.
  • Upstream optionality: Titan DFS shows NPV8 US$813M, IRR 39.4%, payback 3.6 years, and is described as fully permitted.
  • Strong insider alignment: about US$4.3M of insider purchases in Mar–Apr 2026 [Q4 FY26].

Weaknesses

  • No material revenue; FY2026 net loss of US$66.8M, nearly double FY2025 [20-F FY26].
  • Cash of US$35.2M at FY-end, below the year's burn rate [20-F FY26].
  • Accumulated losses of US$176.0M [20-F FY26 Note 18].
  • Reporting-control questions after the March 2026 right-of-use asset correction; ASX price query issued.
  • Ramp hiccups: furnace downtime reduced June-quarter volumes [Q4 FY26].
  • Corporate and administrative cost rose from US$3.3M to US$16.2M year on year in H1 [HY26].

Opportunities

  • 1,400 tpa expansion in 2027 under IBAS.
  • GenX™ could lower capital intensity per tonne.
  • Integrated Atlas–Titan study by end-2026 may reduce Titan capex of US$381.3M.
  • HREC output aligned with US rare-earth security policy.
  • Defence fastener qualification (JLTV) could scale to programme-of-record volumes.
  • Consumer-electronics spherical powder qualification opens a non-defence revenue line.

Threats

  • Active short sellers: short interest around 9.4%; Spruce Point has signalled further scrutiny.
  • Plaintiff-firm securities investigations after March 2026.
  • Repeated dilution: two raises (A$70M and US$50M) within about 12 months, the latest at a ~22% discount.
  • Titan requires project finance not yet secured.
  • Incumbent Kroll producers and powder rivals could cut prices.
  • Policy risk: US budget or administration changes affecting awards.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
16 Apr 2025Chair Hannigan buys 310,500 shares (A$2.65)Insider confidence
29 Jul 2025A$70M placement tranche 1 (A$5.00/share)Funds Virginia ramp
15 Sep 2025Director M. Waller sells 150,000 sharesInsider selling
Sep 2025 qtrCapacity increase, lower unit costs, more US Government funding reportedRamp progress
3 Oct / 12 Nov 2025Spruce Point "Strong Sell" report (70–95% downside scenarios)Major sentiment shock; dates conflict across sources
14 Oct 2025FY2025 Annual Report filedNet loss US$35.3M
Oct 2025Placement completed (A$70M total)Liquidity
Late 2025Up to US$99M SBIR Phase III contractDefence demand vehicle
17 Nov 2025Company response to short reportSays Spruce Point never contacted it
28 Nov 2025AGM passes all resolutions; dissident candidate rejectedGovernance stability
23 Dec 2025Director Tripeny buys sharesInsider buying
30 Jan 2026December 2025 quarterly reportCapacity and funding update
2 Feb 2026CEO 2026 shareholder letter; GenX™ unveiledStrategy roadmap
3–4 Feb 2026CEO and Chair exercise/buy; director Taylor sells 150,000Mixed insider activity
12 Mar 2026HY26 results: loss US$34.8M, cash US$65.8MLoss widened
13 Mar 2026Correction of right-of-use asset figure (US$3.75M, not US$21.45M)Credibility hit; Nasdaq ADS down 27.4% over two sessions to US$29.44 (16 Mar)
16 Mar 2026Response to ASX price query; ASX shares fall ~22% to A$4.09Regulatory scrutiny
Mar 2026US plaintiff law firms announce securities "investigations"Litigation risk
27 Mar 2026CEO and Chair on-market purchasesInsider support
27 Apr 2026March quarterly: 24/7 production; cash US$48.2M; FY26 cash guidance US$36–40MOperational inflection
28–29 Apr 2026CEO, Chair and L. Martin buy shares (Chair ~A$2.08M)Insider support
21 May 2026Six-axis PM press commissionedDownstream capacity
4 Jun 2026Titan DFS: NPV8 US$813M; IRR 39.4%; capex US$381.3MUpstream de-risking
Jun 2026Atlas US$3M agreementResource expansion
Jun 2026 qtrFurnace downtime and maintenance temporarily cut volumesRamp execution risk
1 Jul 2026Atlas acquisition completed—
7–9 Jul 2026US$50M ADS offering at US$21.98 (vs US$28.36 close on 6 Jul)Dilution at ~22% discount; criticised by Spruce Point
Jul 2026US Army GVSC JLTV prototype fastener orderDefence qualification
30 Jul 2026June 2026 quarterly reportRamp and funding update
4–5 Aug 2026Investor webinar (CEO)Company update
28–29 Sep 2026FY2026 results / 20-F: loss US$66.8M; cash US$35.2M; net assets US$88.3MAnnual results
29 Oct 2026 (scheduled)September 2026 quarterly reportNext catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement

2 charts
Income Statement: Net sales consensus rose from USD 12.6 Mn in FY2026 to USD 252 Mn in FY2028.
IperionX Limited — Income Statement
Series (USD Mn)FY2026FY2027FY2028
Net sales consensus12.681.7252
EBITDA consensus-19.728.2139
Net income consensus-19.912.3136

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.